Innvierte Technology Transfer & Deep-Tech, a government-backed fund of funds in Spain, has made its inaugural limited partner commitment, putting €30 million into Montana Children’s Health.
The fund, managed by Ship2B Ventures, will focus exclusively on translating research and innovation into paediatric healthcare solutions, targeting areas such as rare diseases, novel drugs, and nutrition.
The fund has a €50 million target, with the remainder expected to come from family offices and private investors, with whom Ship2B Ventures is currently negotiating.
The Montana Children’s Health Fund aims to make around 15 early-stage investments in Europe-based companies over the coming years. It is positioning itself as the first fund in Europe dedicated solely to pediatric health.
While Montana Children’s Health didn’t explicitly mention spinouts in its press release, Innvierte has university spinoffs as its remit. The Montana fund will also recruit investment team members with tech transfer expertise.
“Montana is created to address a clear need in the European health innovation ecosystem. The backing of the EIF and CDTI validates our thesis and enables us to build a specialised fund with a clear ambition: to generate real impact in children’s lives while, at the same time, contributing to the development of a new model of preventive medicine in Europe.”
Marc Ramis, managing partner of the Montana Children’s Health Fund
Innvierte Technology Transfer & Deep-Tech was set up to invest in venture capital funds focused on global challenges, including healthcare, the climate crisis, and security.
It sits in the Centre for Technological Development & Innovation (CDTI) Innovación, part of the Spanish Ministry of Science, Innovation and Universities. It has €353 million at its disposal, with €300 million coming from the Spanish government and the remainder from the European Investment Fund.
The fund of funds targets the commercialisation of technology emerging from Spanish universities and research institutes.
